Your browser doesn't support javascript.
loading
Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study.
Pignon, B; Peyre, H; Ayrolles, A; Kirkbride, J B; Jamain, S; Ferchiou, A; Richard, J R; Baudin, G; Tosato, S; Jongsma, H; de Haan, L; Tarricone, I; Bernardo, M; Velthorst, E; Braca, M; Arango, C; Arrojo, M; Bobes, J; Del-Ben, C M; Di Forti, M; Gayer-Anderson, C; Jones, P B; La Cascia, C; Lasalvia, A; Menezes, P R; Quattrone, D; Sanjuán, J; Selten, J P; Tortelli, A; Llorca, P M; van Os, J; Rutten, B P F; Murray, R M; Morgan, C; Leboyer, M; Szöke, A; Schürhoff, F.
Affiliation
  • Pignon B; Univ Paris Est Créteil, INSERM, IMRB, AP-HP, Hôpitaux Universitaires H. «Mondor¼, DMU IMPACT, Fondation FondaMental, Créteil F-94010, France.
  • Peyre H; AP-HP, Hôpital universitaire Robert Debré, Service de pédopsychiatrie, Paris 75019, France.
  • Ayrolles A; AP-HP, Hôpital universitaire Robert Debré, Service de pédopsychiatrie, Paris 75019, France.
  • Kirkbride JB; PsyLife Group, Division of Psychiatry, UCL, London W1T 7NF, UK.
  • Jamain S; Univ Paris Est Créteil, INSERM, IMRB, AP-HP, Hôpitaux Universitaires H. «Mondor¼, DMU IMPACT, Fondation FondaMental, Créteil F-94010, France.
  • Ferchiou A; Univ Paris Est Créteil, INSERM, IMRB, AP-HP, Hôpitaux Universitaires H. «Mondor¼, DMU IMPACT, Fondation FondaMental, Créteil F-94010, France.
  • Richard JR; Univ Paris Est Créteil, INSERM, IMRB, AP-HP, Hôpitaux Universitaires H. «Mondor¼, DMU IMPACT, Fondation FondaMental, Créteil F-94010, France.
  • Baudin G; Université de Paris, Laboratoire de Psychopathologie et Processus de Santé, Boulogne Billancourt F-92100, France.
  • Tosato S; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Jongsma H; Centre for Transcultural Psychiatry 'Veldzicht', Balkbrug, the Netherlands.
  • de Haan L; VR Mental Health Group, University Center for Psychiatry, Univerisity Medical Centre Groningen, Groningen, the Netherlands.
  • Tarricone I; Centre for Longitudinal Studies, UCL, London, UK.
  • Bernardo M; Amsterdam UMC, Amsterdam, The Netherlands.
  • Velthorst E; Arkin, Amsterdam, The Netherlands.
  • Braca M; Department of Medical and Surgical Sciences, Bologna University, Bologna, Italy.
  • Arango C; Barcelona Clínic Schizophrenia Unit, Hospital Clínic of Barcelona, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
  • Arrojo M; Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Bobes J; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
  • Del-Ben CM; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA.
  • Di Forti M; Department of Mental Health and Pathological Addictions, Local Health Authority, Bologna 40100, Italy.
  • Gayer-Anderson C; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General.Universitario Gregorio Marañón, Gregorio Marañón, (IiGSM), School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • Jones PB; CIBERSAM, Madrid, Spain.
  • La Cascia C; Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Lasalvia A; Faculty of Medicine and Health Sciences - Psychiatry, Universidad de Oviedo, Oviedo, Spain.
  • Menezes PR; ISPA, INEUROPA CIBERSAM, Oviedo, Spain.
  • Quattrone D; Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Sanjuán J; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
  • Selten JP; South London and Maudsley NHS Mental Health Foundation Trust, London, UK.
  • Tortelli A; Department of Health Service and Population Research, Institute of Psychiatry, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK.
  • Llorca PM; Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, UK.
  • van Os J; CAMEO, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, UK.
  • Rutten BPF; Department Biomedicine, Neuroscience and Advanced Diagnostics, School of Medicine, University of Palermo, Palermo, Italy.
  • Murray RM; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Morgan C; Department of Preventive Medicine, Faculdade de Medicina, Universidade of São Paulo, São Paulo, Brazil.
  • Leboyer M; Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Szöke A; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Madrid, Spain.
  • Schürhoff F; Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, Valencia, Spain.
Epidemiol Psychiatr Sci ; 31: e68, 2022 Sep 27.
Article de En | MEDLINE | ID: mdl-36165168
ABSTRACT

AIMS:

Gene x environment (G×E) interactions, i.e. genetic modulation of the sensitivity to environmental factors and/or environmental control of the gene expression, have not been reliably established regarding aetiology of psychotic disorders. Moreover, recent studies have shown associations between the polygenic risk scores for schizophrenia (PRS-SZ) and some risk factors of psychotic disorders, challenging the traditional gene v. environment dichotomy. In the present article, we studied the role of GxE interaction between psychosocial stressors (childhood trauma, stressful life-events, self-reported discrimination experiences and low social capital) and the PRS-SZ on subclinical psychosis in a population-based sample.

METHODS:

Data were drawn from the EUropean network of national schizophrenia networks studying Gene-Environment Interactions (EU-GEI) study, in which subjects without psychotic disorders were included in six countries. The sample was restricted to European descendant subjects (n = 706). Subclinical dimensions of psychosis (positive, negative, and depressive) were measured by the Community Assessment of Psychic Experiences (CAPE) scale. Associations between the PRS-SZ and the psychosocial stressors were tested. For each dimension, the interactions between genes and environment were assessed using linear models and comparing explained variances of 'Genetic' models (solely fitted with PRS-SZ), 'Environmental' models (solely fitted with each environmental stressor), 'Independent' models (with PRS-SZ and each environmental factor), and 'Interaction' models (Independent models plus an interaction term between the PRS-SZ and each environmental factor). Likelihood ration tests (LRT) compared the fit of the different models.

RESULTS:

There were no genes-environment associations. PRS-SZ was associated with positive dimensions (ß = 0.092, R2 = 7.50%), and most psychosocial stressors were associated with all three subclinical psychotic dimensions (except social capital and positive dimension). Concerning the positive dimension, Independent models fitted better than Environmental and Genetic models. No significant GxE interaction was observed for any dimension.

CONCLUSIONS:

This study in subjects without psychotic disorders suggests that (i) the aetiological continuum hypothesis could concern particularly the positive dimension of subclinical psychosis, (ii) genetic and environmental factors have independent effects on the level of this positive dimension, (iii) and that interactions between genetic and individual environmental factors could not be identified in this sample.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Troubles psychotiques / Schizophrénie Type d'étude: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Epidemiol Psychiatr Sci Année: 2022 Type de document: Article Pays d'affiliation: France

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Troubles psychotiques / Schizophrénie Type d'étude: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Epidemiol Psychiatr Sci Année: 2022 Type de document: Article Pays d'affiliation: France